advertisement
Pfeiffer N 68
Showing records 1 to 25 | Display all abstracts from Pfeiffer N73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Teister J
Scientific reports 2017; 7: 6260
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Pillunat LE
Clinical Ophthalmology 2017; 11: 1051-1064
72845 The Prevalence of Glaucoma in Young People
Marx-Gross S
Deutsches Ärzteblatt international 2017; 114: 204-210
73145 Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures
Laspas P
PLoS ONE 2017; 12: e0178099
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Anders F
PLoS ONE 2017; 12: e0175451
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Lorenz K
Trials 2017; 18: 128
73029
Höhn R
Klinische Monatsblätter für Augenheilkunde 2017; 234: 931-948
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Höhn R
British Journal of Ophthalmology 2017; 101: 1633-1637
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Funke S
Expert review of proteomics 2017; 14: 311-334
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Anders F
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Teister J
PLoS ONE 2017; 12: e0175451
73029
Pfeiffer N
Klinische Monatsblätter für Augenheilkunde 2017; 234: 931-948
72842 Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study
Mirshahi A
British Journal of Ophthalmology 2017; 101: 1633-1637
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Erb C
Clinical Ophthalmology 2017; 11: 1051-1064
73128 Proteomic profiling reveals crucial retinal protein alterations in the early phase of an experimental glaucoma model
Teister J
Graefe's Archive for Clinical and Experimental Ophthalmology 2017; 255: 1395-1407
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Perumal N
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Laubert-Reh D
Deutsches Ärzteblatt international 2017; 114: 204-210
73546 Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Anders F
Scientific reports 2017; 7: 6260
73145 Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures
Culmann PD
PLoS ONE 2017; 12: e0178099
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Scheller Y
Trials 2017; 18: 128
73145 Revision of encapsulated blebs after trabeculectomy: Long-term comparison of standard bleb needling and modified needling procedure combined with transconjunctival scleral flap sutures
Grus FH
PLoS ONE 2017; 12: e0178099
72603 The potential impact of recent insights into proteomic changes associated with glaucoma
Bell K
Expert review of proteomics 2017; 14: 311-334
72845 The Prevalence of Glaucoma in Young People
Schneider A
Deutsches Ärzteblatt international 2017; 114: 204-210
72797 Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
Liu A
PLoS ONE 2017; 12: e0175451
72660 A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol f
Bell K
Trials 2017; 18: 128
